Baxter To Pay Up To $330M To Buy ApaTech

Law360, New York (March 1, 2010, 1:03 PM EST) -- Pharmaceutical and medical device maker Baxter International Inc. has agreed to buy U.K.-based orthobiologic products company ApaTech for up to $330 million in a deal that will allow Baxter to enter the emerging bone fusion market.

The companies said Monday that Baxter will pay $240 million cash for the company. Illinois-based Baxter also may make additional payments of up to $90 million if certain sales milestones are achieved.

The deal allows Baxter to acquire ApaTech's Actifuse product, a silicate substituted calcium phosphate synthetic bone graft material...
To view the full article, register now.